Why the study?
Gastrointestinal bleeding is frequent in patients with AF treated with oral anticoagulation, but the extent to which lower GI-bleeding represents unmasking of occult colorectal cancer was unknown.
Does lower gastrointestinal bleeding indicate an increased risk of colorectal cancer in patients with atrial fibrillation on oral anticoagulation?
Does lower gastrointestinal bleeding indicate an increased risk of colorectal cancer in patients with atrial fibrillation on oral anticoagulation?
Lower GI bleeding in anticoagulated AF patients is strongly associated with a subsequent diagnosis of colorectal cancer, highlighting the need for thorough investigation rather than attributing the bleeding solely to anticoagulation.
Answers are grounded in this paper and cite their sources.
May support colorectal evaluation after lower GI bleeding in anticoagulated AF; hypothesis-generating and requires prospective confirmation before changing practice.
AIMS: Gastrointestinal bleeding (GI-bleeding) is frequent in patients with atrial fibrillation (AF) treated with oral anticoagulation (OAC) therapy. We sought to investigate to what extent lower GI-bleeding represents the unmasking of an occult colorectal cancer. METHODS AND RESULTS: A total of 125 418 Danish AF patients initiating OAC therapy were identified using Danish administrative registers. Non-parametric estimation and semi-parametric absolute risk regression were used to estimate the absolute risks of colorectal cancer in patients with and without lower GI-bleeding. During a maximum of 3 years of follow-up, we identified 2576 patients with lower GI-bleeding of whom 140 patients were subsequently diagnosed with colorectal cancer within the first year of lower GI-bleeding. In all age groups, we observed high risks of colorectal cancer after lower GI-bleeding. The absolute 1-year risk ranged from 3.7% [95% confidence interval (CI) 2.2-6.2] to 8.1% (95% CI 6.1-10.6) in the age groups ≤65 and 76-80 years of age, respectively. When comparing patients with and without lower GI-bleeding, we found increased risk ratios of colorectal cancer across all age groups with a risk ratio of 24.2 (95% CI 14.5-40.4) and 12.3 (95% CI 7.9-19.0) for the youngest and oldest age group of ≤65 and >85 years, respectively. CONCLUSION: In anticoagulated AF patients, lower GI-bleeding conferred high absolute risks of incident colorectal cancer. Lower GI-bleeding should not be dismissed as a benign consequence of OAC therapy but always examined for a potential underlying malignant cause.
No takes yet. Share an insight, caveat, or question.
Rasmussen et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: